HFA Premium Access

Tafamidis treatment in patients with transthyretin amyloid cardiomyopathy

Congress Presentation

About the speaker

Doctor Rene Rettl

Medical University of Vienna, Vienna (Austria)
0 follower

3 more presentations in this session

Effect of SGLT2 inhibitors on diastolic function in patients with non-obstructive hypertrophic cardiomyopathy

Speaker: Doctor M. Subramanian (Hyderabad, IN)

Thumbnail

Efficacy of additional medical therapies in patients with heart failure, a reduced ejection fraction and chronic kidney disease already receiving neurohormonal inhibitors: a network meta-analysis

Speaker: Doctor V. De Marzo (Genoa, IT)

Thumbnail

Target dose of heart failure medications is associated with better mortality/morbidity: data from the Swedish Heart Failure Registry

Speaker: Mr D. Rodolico (Pisa, IT)

Thumbnail

Access the full session

Young Investigator Award: clinical research

Speakers: Doctor R. Rettl, Doctor M. Subramanian, Doctor V. De Marzo, Mr D. Rodolico
Thumbnail

About the event

Image

Heart Failure 2021

29 June - 1 July 2021

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb